MAPT-AS1
Contents
Annotated Information
Approved Symbol
MAPT-AS1 (MAPT antisense RNA 1)
Chromosome
17q21.31
Effect of MAPT-AS1 over- and knock-down expression on MAPT expression in HEK293 and SK-N-MC cells. [1].
RefSeq(supplied by NCBI)
NR_024559
Characteristics
MAPT-AS1 is an 840 bp lncRNA transcribed from the anti-sense strand of the MAPT promoter region.[2]
Expression
The siRNA s237111 can knock-down the expression of MAPT-AS1.The sequence of the s237111 siRNA is described in the table below.[1]
| sense | antisense |
|---|---|
| 5’-CCACUUCAUGGAUAAGUAAtt-3’ | 5’-UUACUUAUCCAUGAAGUGGgt-3’[1] |
Function
MAPT-AS1 has an inhibitory effect on the expression of a major neurodegenerative gene, MAPT. MAPT-AS1 may serve as a sensitive biomarker of disease state in Parkinson’s disease, as well as a potential therapeutic target for inhibiting the expression of MAPT. [1]
Labs working on this lncRNA
- Genomics Institute, University of California Santa Cruz, Santa Cruz, CA 95064, USA.[2]
- Neuroscience Research Australia, Randwick, NSW, Australia.[1]
- School of Medical Sciences, University of New South Wales, Sydney, NSW, Australia.[1]
